BeOne Medicines
Marc Polk is an accomplished legal professional with extensive experience in litigation and risk management within the biotechnology and pharmaceutical sectors. Currently serving as the Head of Litigation and Enterprise Risk Management at BeiGene since November 2021, Marc oversees all litigation matters while leading a global Enterprise Risk Management program. Prior to this, Marc held the position of Head of Litigation and Employment at Amneal Pharmaceuticals, where strategic legal navigation and risk mitigation were key responsibilities. As Chief Legal Counsel at Stryker, Marc managed legal exposures and commercial initiatives for a major medical device company. Earlier career roles include Chief Litigation Counsel at Covidien (now part of Medtronic) and Associate General Counsel at Nutter, where representation encompassed a wide range of legal issues, including product liability and IP litigation. Marc holds a Juris Doctor from Cornell Law School and a Bachelor of Arts from Franklin & Marshall College.
This person is not in any teams
This person is not in any offices
BeOne Medicines
33 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.